Trial Information
Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients
The aim of this pilot study is to examine global and regional LV systolic and diastolic
function, cardiac output, cardiac reserve, VO2peak and CVD risk profile in males recently
diagnosed with testicular cancer treated with surgery alone or surgery and chemotherapy.
Inclusion Criteria:
- surgery and surveillance
- surgery and multi-cycle chemotherapy
- both good and intermediate prognosis seminoma and non-seminomatous germ cell
testicular tumors
- Karnofsky performance index > 70%
- no contraindications to cardiopulmonary testing
Exclusion Criteria:
- documented cardiovascular disease or evidence of myocardial ischemia on the
incremental exercise (VO2peak) test.
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Prospective
Principal Investigator
Mark Haykowsky, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Alberta
Authority:
Canada: Health Canada
Study ID:
GU-24167
NCT ID:
NCT00705094
Start Date:
September 2008
Completion Date:
July 2012
Related Keywords:
- Testicular Cancer
- Seminoma
- Non-seminomatous
- cardiovascular risk factors
- cardiac function
- VO2peak
- Chemotherapy
- Seminoma
- Testicular Neoplasms